| The settlement resolves allegations that Abbott 
				paid well-known doctors for teaching assignments, speaking 
				engagements and conferences, expecting that they would arrange 
				for the hospitals with which they were affiliated to buy 
				Abbott's carotid, biliary and peripheral vascular products.
 				This activity violated the federal Anti-Kickback Act and led to 
				the submission of false Medicare claims, the government said, in 
				a case brought under the federal False Claims Act.
 				Carotid and peripheral vascular products are implanted to treat 
				circulatory disorders by increasing blood flow, while biliary 
				products are implanted to treat obstructions in the bile ducts, 
				the government said.
 				"Patients have a right to treatment decisions that are based on 
				their own medical needs, not the personal financial interests of 
				their health care providers," Assistant Attorney General Stuart 
				Delery of the Justice Department's civil division said in a 
				statement.
 				Abbott spokeswoman Angela Duff said the Abbott Park, 
				Illinois-based company is pleased to settle, and did so to avoid 
				the uncertainty and cost of lengthy litigation. "Abbott believes 
				its actions were appropriate at all times," she added.
 				The Justice Department said the settlement resolves allegations 
				originally brought by former Abbott employees Douglas Gray and 
				Steven Peters. They will receive more than $1 million from the 
				settlement, the department added.
 				(Reporting by Jonathan Stempel in 
				New York; editing by Richard Chang) 
			[© 2013 Thomson Reuters. All rights 
				reserved.] Copyright 2013 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
				 |